Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients'G Freyer, A-C Braud, P Chaibi, et al.
The Journal of Nutrition, Health & Aging|January 24, 2017
Slow Gait Speed Is an Independent Predictor of Early Death in Older Cancer Outpatients: Results from a Prospective Cohort StudyF Pamoukdjian, V Lévy, G Sebbane, et al.
Cancer|December 18, 2001
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinomaL Zelek, S Barthier, M Riofrio, et al.
British Journal of Cancer|June 1, 2006
A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancerL Zelek, A Yovine, E Brain, et al.
American Journal of Clinical Oncology|July 28, 2001
Gastric metastases from breast cancer: a retrospective series of 12 patientsL Zelek, P H Cottu, L Mignot, et al.
Gynecologie, Obstetrique & Fertilite|May 28, 2014
[Impact of omission of axillary dissection on adjuvant therapy in patients with metastatic sentinel lymph nodes according to the ACOSOG Z0011 criteria]A Roosen, R Lousquy, A Bricou, et al.
Revue Des Maladies Respiratoires|January 29, 2019
[Can nivolumab be used safely in idiopathic pulmonary fibrosis?]B Duchemann, M Didier, M-C Pailler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-upL Zelek, A Llombart-Cussac, P Terrier, et al.
Bulletin Du Cancer|February 1, 1997
[Angiosarcoma of the breast. Apropos of 8 cases and review of the literature]J L Molitor, A Llombart, J M Guinebretière, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2013
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)C Delbaldo, D Serin, M Mousseau, et al.
Pageof 3